Charlesworth et al (11) reviewed 11 studies (excluding case studies) of VHL-associated pancreatic lesions and identified that 211 (15%) of the 1,442 patients with VHL also exhibited pancreatic NETs. This evidence concerns the gene VHL and pancreatic neuroendocrine tumor.